UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037889
Receipt number R000043056
Scientific Title Intensified multifactorial intervention on renal outcomes in DKD outpatients
Date of disclosure of the study information 2019/10/15
Last modified on 2019/09/02 12:21:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intensified multifactorial intervention on renal outcomes in DKD outpatients

Acronym

Intensified multifactorial intervention on renal outcomes in DKD outpatients

Scientific Title

Intensified multifactorial intervention on renal outcomes in DKD outpatients

Scientific Title:Acronym

Intensified multifactorial intervention on renal outcomes in DKD outpatients

Region

Japan


Condition

Condition

Diabetic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Effeciveness of outpatient intensive treatment and management targets sheet for the prognosis of diabetic kidney disease

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

end stage kidney disease

Key secondary outcomes

anunual eGFR change rate,MACE,urinary protein change,achievement level of management targets sheet


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Outpatient-intensive treatment by using a management target sheet (+)

Interventions/Control_2

Outpatient-intensive treatment by using a management target sheet (-)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients who have a new visit to the Department of Nephrology and are scheduled to go to the hospital for more than half a year
2) Diabetic patients in the course of diabetic kidney disease
3) Diabetic nephropathy stage 2 to 4
4) Patients who are 18 years old or older and younger than 90 years old at the time of registration
5) Gender: Any gender
6) General condition that allows medical care in an outpatient setting
7) Patients who have no complications of heart, brain or vascular disease or are in a stable condition
8) Patients whose written consent was obtained by the patient's own free will

Key exclusion criteria

1) Patients who require hospitalization or new treatment at the time of registration
2) Patients suffering from serious malignant diseases, infections, heart, brain, blood vessels, liver diseases
3) Patients suffering from malignant diseases, infectious diseases, heart, brain, blood vessels, and liver diseases that are considered to have a limited life prognosis within half a year
4) Patients with eGFR of 15 ml / min or less and uremic symptoms
5) Female patients who are pregnant or may be pregnant
6) Patients with primary chronic glomerulonephritis (IgA nephropathy, membranous nephropathy, minimal change nephrosis)
7) Patients with purpura nephropathy, lupus nephritis, systemic vasculitis
8) Patients with acute renal failure at the time of registration
9) Patients who have prerenal failure and postrenal failure at the time of registration
10) When the research supervisor or research director determines that participation in this research is not appropriate

Target sample size

240


Research contact person

Name of lead principal investigator

1st name Honami
Middle name
Last name Mori

Organization

JCHO Saitama Northern Medical Center

Division name

Department of Nephropathy

Zip code

3318625

Address

1-851, Miyahara-cho, Kita-ku, Saitama City, Saitama

TEL

0486631671

Email

honamimori33@gmail.com


Public contact

Name of contact person

1st name Honami
Middle name
Last name Mori

Organization

JCHO Saitama Northern Medical Center

Division name

Department of Nephropathy

Zip code

3318625

Address

1-851, Miyahara-cho, Kita-ku, Saitama City, Saitama

TEL

0486631671

Homepage URL


Email

honamimori33@gmail.com


Sponsor or person

Institute

Japan community healthcare organization

Institute

Department

Personal name



Funding Source

Organization

Japan community healthcare organization reseach business

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

JPN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

JCHO Central Ethics Review Committee

Address

3-22-12, Takanawa, Minato-ku, Tokyo

Tel

0334450862

Email

iryoka@jcho.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 10 Month 15 Day

Date of IRB

2019 Year 08 Month 22 Day

Anticipated trial start date

2019 Year 11 Month 01 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 09 Month 02 Day

Last modified on

2019 Year 09 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043056


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name